Key stats
About iShares Global Healthcare ETF
Expense ratio
0.41%
Home page
Inception date
Nov 13, 2001
IXJ offers marketlike exposure to global pharmaceutical, biotechnology, and medical device companies. The fund pulls from the S&P Global 1200 universe, which effectively screens out small-caps, giving the fund a large-cap tilt compared to our benchmark. Aside from that, geographic and sector weights look neutral and make it a viable entry-point to global healthcare. BlackRock Fund Advisors uses a sampling approach to indexing. This means the fund may not hold all the stocks of the underlying index but will hold securities that collectively have the same investment profile. Stocks within IXJ are selected and weighted by float-adjusted market-cap. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.03%
Health Technology83.23%
Health Services12.60%
Distribution Services2.14%
Retail Trade0.79%
Commercial Services0.23%
Technology Services0.05%
Bonds, Cash & Other0.97%
Mutual fund0.56%
Cash0.37%
Miscellaneous0.05%
Stock breakdown by region
North America72.38%
Europe21.43%
Asia4.57%
Oceania1.56%
Latin America0.07%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history